# Safety and Efficacy of Insulin Aspart in Type 2 Diabetes

> **NCT01649570** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 123 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT01649570
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2012-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01649570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01649570, "Safety and Efficacy of Insulin Aspart in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01649570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*